We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
63 hedge funds and large institutions have $50.2M invested in CASI Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 10
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
11% more funds holding
Funds holding: 57 → 63 (+6)
0.1% more ownership
Funds ownership: 1.14% → 1.24% (+0.1%)
38% less capital invested
Capital invested by funds: $80.8M → $50.2M (-$30.6M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
63
Holders Change
+6
Holders Change %
+10.53%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
22
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$1.33M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.25M |
| 3 |
Charles Schwab
San Francisco,
California
|
+$1.21M |
| 4 |
BlackRock
New York
|
+$1.01M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$423K |
Top Sellers
| 1 |
WSC
Wellington Shields & Co
New York
|
-$383K |
| 2 |
Morgan Stanley
New York
|
-$378K |
| 3 |
RA
Royce & Associates
New York
|
-$288K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$188K |
| 5 |
MC
Moors & Cabot
Boston,
Massachusetts
|
-$187K |
